While most patients with follicular lymphoma (FL) who relapse within 24 months after first-line treatment (POD24) have a poor prognosis, some show notable survival. POD24 FL patients constituted 15% ...
Prognostic value of the absolute lymphocyte count reduction in patients with diffuse large B-cell lymphoma treated with R-CHOP. Background: Tracer retention on post-therapy 18F-fluorodeoxglucose (FDG) ...
Long-term results of the GELA study comparing R-CHOP and CHOP chemotherapy in older patients with diffuse large B-cell lymphoma show good survival in poor-risk patients No significant financial ...
—Risk stratification in follicular lymphoma relies on clinical parameters, lab tests, and histology to determine which patients should receive early treatment. Genetic tests may soon be added to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results